Cross-referencing clinical data
A pairing appears on this page only when a trial gave both ingredients together and measured the result. Viniferin has none that clears that bar.
Stitching two separate single-ingredient studies into a pairing is the one thing this engine will not do. When a study of the combination itself holds up at source, it lands here with its citation.
No invented synergy. Where actives were studied on their own rather than together, the record shows each on its own evidence, never a combined effect no trial measured.
Research strength. Research strength says how much work stands behind the combination. It is never a product score.
Independent record. Every finding is cited to a named trial, dated, and never written by the brand.
20 pairings are live across the library today. Checked 20 July 2026.
No study gave these as a pair, so they are not in the card above. But the reason they belong together is settled biochemistry, not a guess, so it is worth knowing.
Epsilon-viniferin is a resveratrol dimer formed by oxidative coupling of two resveratrol units, and alpha-viniferin is the corresponding trimer. Grapevine extracts therefore deliver both the monomer and its oligomers together, and the ratio shifts with plant part and processing. The chemistry is settled, but sharing a backbone does not mean the two behave the same once absorbed.
Both come from Vitis vinifera, and grapevine cane or shoot extracts commonly carry stilbenes alongside the proanthocyanidins that dominate seed extracts. Formulators pair them to widen the polyphenol profile from a single plant source. This is compositional overlap, not a demonstrated combined effect.
Pterostilbene is a dimethylated stilbene that resists phase II conjugation better than resveratrol does, so it is often stacked with grapevine stilbene extracts. The pairing is built on class chemistry and pharmacokinetic reasoning rather than on a trial of the combination. No human study has tested viniferin plus pterostilbene together.
Stilbenes are cleared fast by glucuronidation and sulfation in the gut wall and liver, which is why unmodified plasma levels stay low. Piperine slows glucuronidation, and that is the stated reason it appears in stilbene formulas. The same inhibition is not selective, so it can raise exposure to co-administered medicines as well.
Quercetin is itself a heavy substrate for sulfotransferases and glucuronosyltransferases, the same enzymes that clear stilbenes. Co-ingestion at high doses can slow conjugation of both, raising unconjugated levels of each. That is a pharmacokinetic prediction from shared enzymology, not a measured outcome in people taking viniferin.
Viniferins are larger and more lipophilic than resveratrol and dissolve poorly in water, which limits how much ever leaves a dry capsule. Phospholipid dispersions and lecithin-based carriers are the standard workaround for this class. Better dispersion is a formulation gain and does not by itself demonstrate a physiological effect.
A medium-chain triglyceride vehicle keeps stilbene oligomers in solution in a softgel and supports dispersion in the gut. This is the same rationale used for other poorly soluble polyphenols. It changes delivery, not activity.
Stilbene oligomers form through oxidative coupling in the plant, and the same oxidative chemistry continues in a finished product exposed to air, light and metal traces. Ascorbate is used as a formulation antioxidant to slow that drift. The relevance here is shelf chemistry, and no human data links the pair to any measured endpoint.
Nothing specific on file for Viniferin. Match the label to the daily amount above, and tell your doctor what you take.
Not medical advice. Show the label to your pharmacist.These are the studies our verdict leans on, chosen from the 3 we read for Viniferin. The full linked list is below.
1 source behind our Viniferin verdict: peer-reviewed studies and registered clinical trials. Every one links straight to PubMed, the journal, or ClinicalTrials.gov. Read them yourself.
Evidence surfaced via Semantic Scholar (Allen Institute for AI) and ClinicalTrials.gov. Ranked by study type and citation weight, not cherry-picked.
FDA Disclaimer: These statements have not been evaluated by the Food and Drug Administration. This information is for educational purposes only and is not intended to diagnose, treat, cure, or prevent any disease. Consult your healthcare provider before starting any supplement regimen.